N/A N=26 Diagnostic

Dual Energy Cone-Beam Computed Tomography (DE-CBCT) Assessment of Jaw Bone Density

Dental Diseases

Bottom Line

View on ClinicalTrials.gov: NCT04686084 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jan 2023

Primary outcome: Primary: Bone Density Assessment — 0.48; 0.46 g/cc

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Dual-energy computed tomography scan (Device)
Age: Adult, Older Adult · 21+ yrs
Sex: All
Sponsor: University of California, Los Angeles
Primary completion: Nov 2021

Outcome Measures

Outcome	Result	p-value
PRIMARY Bone Density Assessment	0.48; 0.46	—

Summary

Current radiologic imaging modalities used in dentistry provide information on the morphology of the hard tissues. Additional information on the density of bone has practical relevance, for example, in dental implant treatment planning, where local bone quality is a known strong predictor of successful implant osseointegration. The Dual-Energy Cone Beam Computed Tomography (DE-CBCT) device is designed to overcome limitations of traditional imaging and will provide assessment of jaw bone density in additional to morphological information. This clinical trial will examine the application of DE-CBCT to assess jaw bone density and compare Hounsfield units (HU) values with multidetector CT, an established standard for assessing BD.

Eligibility Criteria

Inclusion Criteria

Patients who need x-ray imaging for dental treatment planning and/or diagnosis
Males or females aged older than 21
Can follow instructions to be positioned into the CT scanner
Can remain physically immobile during the CT scan acquisition
Voluntarily sign and date the informed consent

Exclusion Criteria

Pregnancy
Patients who are unable to comprehend the risks of the study to provide informed consent
Extensive dental restorations, maxillofacial prosthesis, or orthopedic hardware that likely may cause artifacts and degrade quality, as determined by the study radiologists

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04686084). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.